Clinova Limited is a limited company established in 2006, operating under registration number 05826113. The company’s registered address is International House, Southampton International Business Park, Southampton, SO18 2RZ, within the United Kingdom. Clinova specializes in research and experimental development focused on biotechnology, leveraging advanced scientific methodologies. Clinova’s core business involves the creation and provision of tailored solutions for clients within the biotechnology sector. This includes supporting pharmaceutical companies through research, development, and optimization of novel therapies and diagnostics. The company’s expertise spans a range of areas, encompassing molecular biology, drug discovery, and formulation development. Clinova’s activities are primarily centered on providing consulting services, custom synthesis, and analytical testing. While the company does not currently have a significant international presence, it maintains a strong focus on supporting businesses within the United Kingdom and Europe. Clinova is classified as a worker, holding a rating of A, indicating a moderate level of responsibility and expertise. The company’s SIC codes include: - 46460: Wholesale of pharmaceutical goods - 72110: Research and experimental development on biotechnology - 72190: Other research and experimental development on natural sciences and engineering - 86900: Other human health activities.

Clinova Limited is a limited company established in 2006, operating under registration number 05826113. The company’s registered address is International House, Southampton International Business Park, Southampton, SO18 2RZ, within the United Kingdom. Clinova specializes in research and experimental development focused on biotechnology, leveraging advanced scientific methodologies. Clinova’s core business involves the creation and provision of tailored solutions for clients within the biotechnology sector. This includes supporting pharmaceutical companies through research, development, and optimization of novel therapies and diagnostics. The company’s expertise spans a range of areas, encompassing molecular biology, drug discovery, and formulation development. Clinova’s activities are primarily centered on providing consulting services, custom synthesis, and analytical testing. While the company does not currently have a significant international presence, it maintains a strong focus on supporting businesses within the United Kingdom and Europe. Clinova is classified as a worker, holding a rating of A, indicating a moderate level of responsibility and expertise. The company’s SIC codes include: - 46460: Wholesale of pharmaceutical goods - 72110: Research and experimental development on biotechnology - 72190: Other research and experimental development on natural sciences and engineering - 86900: Other human health activities.